The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

PCOLCE  -  procollagen C-endopeptidase enhancer

Homo sapiens

Synonyms: PCPE, PCPE-1, PCPE1, Procollagen C-endopeptidase enhancer 1, Procollagen C-proteinase enhancer 1, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of PCOLCE

  • Recently, sequencing of a human expressed sequence tag, which maps near the primary open angle glaucoma region on chromosome 3q21, showed it to encode a novel protein with only 43% identity with PCPE but with a similar domain structure [1].
  • Nobiletin and PCPE give efficacious antiproliferation effects on B16 mouse melanoma cell with IC50 values 88.6 microM and 62.96 microg/mL, respectively, by the MTT test [2].
 

High impact information on PCOLCE

 

Biological context of PCOLCE

  • The human enhancer gene, PCOLCE, is localized to 7q21.3-->q22, the same chromosomal region containing the type I collagen alpha 2 chain gene, COL1A2 [7].
  • PCPE2 is shown to be a glycoprotein that differs markedly in the nature of its glycosylation from that of PCPE1 [1].
  • These data also indicate that PCOLCE is located within a 10- to 15-cM region of conserved synteny between human chromosome 7 and mouse chromosome 5 [8].
  • In contrast, the association/dissociation kinetics of intact procollagen molecules on immobilized PCPE were relatively slow, corresponding to a dissociation constant of 1 nM [9].
  • N-terminal sequences of the inhibitor matched amino acid sequences within the C-terminal domain of a protein known as procollagen C-terminal proteinase enhancer (PCPE) [10].
 

Anatomical context of PCOLCE

  • Consistent with a possible role in leiomyomata, PCOLCE is shown to be expressed at relatively high levels in uterus [11].
 

Associations of PCOLCE with chemical compounds

  • PCPE2 is also shown to have markedly stronger affinity for heparin than PCPE1, which may account for higher affinities for cell layers [1].
  • Comparison of the N-terminal domain of TIMP with CT-PCPE revealed that both contained six cysteine residues [10].
  • The mixtures PC with CO, both in the presence of 2 and 5 mM calcium, and PCPE with CO at 2 mM calcium concentration had surface properties significantly better than those of ALEC and Exosurf and equivalent to those of Survanta [12].
  • Crude extracts from citrus peel (C. unshiu Marc.) were extracted with 95% ethanol and fractionated by petroleum ether (PCPE) [13].
 

Regulatory relationships of PCOLCE

  • Substrate-specific modulation of a multisubstrate proteinase. C-terminal processing of fibrillar procollagens is the only BMP-1-dependent activity to be enhanced by PCPE-1 [14].
  • Purified CT-PCPE inhibited MMP-2 with an IC(50) value much greater than that of TIMP-2 [10].
 

Other interactions of PCOLCE

 

Analytical, diagnostic and therapeutic context of PCOLCE

References

  1. PCOLCE2 encodes a functional procollagen C-proteinase enhancer (PCPE2) that is a collagen-binding protein differing in distribution of expression and post-translational modification from the previously described PCPE1. Steiglitz, B.M., Keene, D.R., Greenspan, D.S. J. Biol. Chem. (2002) [Pubmed]
  2. Tyrosinase inhibitory effects and inhibition mechanisms of nobiletin and hesperidin from citrus peel crude extracts. Zhang, C., Lu, Y., Tao, L., Tao, X., Su, X., Wei, D. J Enzyme Inhib Med Chem (2007) [Pubmed]
  3. Mammalian Tolloid-like 1 Binds Procollagen C-proteinase Enhancer Protein 1 and Differs from Bone Morphogenetic Protein 1 in the Functional Roles of Homologous Protein Domains. Ge, G., Zhang, Y., Steiglitz, B.M., Greenspan, D.S. J. Biol. Chem. (2006) [Pubmed]
  4. Identification of the minimal domain structure of bone morphogenetic protein-1 (BMP-1) for chordinase activity: chordinase activity is not enhanced by procollagen C-proteinase enhancer-1 (PCPE-1). Petropoulou, V., Garrigue-Antar, L., Kadler, K.E. J. Biol. Chem. (2005) [Pubmed]
  5. NMR structure of the netrin-like domain (NTR) of human type I procollagen C-proteinase enhancer defines structural consensus of NTR domains and assesses potential proteinase inhibitory activity and ligand binding. Liepinsh, E., Banyai, L., Pintacuda, G., Trexler, M., Patthy, L., Otting, G. J. Biol. Chem. (2003) [Pubmed]
  6. Low resolution structure determination shows procollagen C-proteinase enhancer to be an elongated multidomain glycoprotein. Bernocco, S., Steiglitz, B.M., Svergun, D.I., Petoukhov, M.V., Ruggiero, F., Ricard-Blum, S., Ebel, C., Geourjon, C., Deleage, G., Font, B., Eichenberger, D., Greenspan, D.S., Hulmes, D.J. J. Biol. Chem. (2003) [Pubmed]
  7. Type I procollagen COOH-terminal proteinase enhancer protein: identification, primary structure, and chromosomal localization of the cognate human gene (PCOLCE). Takahara, K., Kessler, E., Biniaminov, L., Brusel, M., Eddy, R.L., Jani-Sait, S., Shows, T.B., Greenspan, D.S. J. Biol. Chem. (1994) [Pubmed]
  8. Fine mapping of the human and mouse genes for the type I procollagen COOH-terminal proteinase enhancer protein. Takahara, K., Osborne, L., Elliott, R.W., Tsui, L.C., Scherer, S.W., Greenspan, D.S. Genomics (1996) [Pubmed]
  9. Interaction properties of the procollagen C-proteinase enhancer protein shed light on the mechanism of stimulation of BMP-1. Ricard-Blum, S., Bernocco, S., Font, B., Moali, C., Eichenberger, D., Farjanel, J., Burchardt, E.R., van der Rest, M., Kessler, E., Hulmes, D.J. J. Biol. Chem. (2002) [Pubmed]
  10. Post-translational proteolytic processing of procollagen C-terminal proteinase enhancer releases a metalloproteinase inhibitor. Mott, J.D., Thomas, C.L., Rosenbach, M.T., Takahara, K., Greenspan, D.S., Banda, M.J. J. Biol. Chem. (2000) [Pubmed]
  11. Structural organization and expression patterns of the human and mouse genes for the type I procollagen COOH-terminal proteinase enhancer protein. Scott, I.C., Clark, T.G., Takahara, K., Hoffman, G.G., Greenspan, D.S. Genomics (1999) [Pubmed]
  12. Comparison of in vitro surface properties of clove oil-phospholipid suspensions with those of ALEC, Exosurf and Survanta. Banerjee, R., Bellare, J.R. Pulmonary pharmacology & therapeutics. (2001) [Pubmed]
  13. Tyrosinase inhibitory effects and inhibition mechanisms of nobiletin and hesperidin from citrus peel crude extracts. Zhang, C., Lu, Y., Tao, L., Tao, X., Su, X., Wei, D. J Enzyme Inhib Med Chem (2007) [Pubmed]
  14. Substrate-specific modulation of a multisubstrate proteinase. C-terminal processing of fibrillar procollagens is the only BMP-1-dependent activity to be enhanced by PCPE-1. Moali, C., Font, B., Ruggiero, F., Eichenberger, D., Rousselle, P., François, V., Oldberg, A., Bruckner-Tuderman, L., Hulmes, D.J. J. Biol. Chem. (2005) [Pubmed]
  15. The NTR module: domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases. Bányai, L., Patthy, L. Protein Sci. (1999) [Pubmed]
  16. PCOLCE deletion and expression analyses in uterine leiomyomata. Ligon, A.H., Scott, I.C., Takahara, K., Greenspan, D.S., Morton, C.C. Cancer Genet. Cytogenet. (2002) [Pubmed]
 
WikiGenes - Universities